Strong performance on HIV drugs for mothers doesn't guarantee optimal care for infants, survey shows
Protease inhibitor therapy doesn't reduce the risk of malaria for HIV-positive pregnant women
High rates of drug resistance among HIV-positive infants in South Africa
HIV incidence is high among pregnant and postpartum women and increases the risk of mother-to-child transmission
Efavirenz-based ART matches lopinavir/ritonavir for perinatal HIV treatment
Sexually transmitted infections greatly increase the risk of HIV infection in pregnancy
Lopinavir/ritonavir or 3TC PrEP equally protective against infant HIV infection during breastfeeding
Maternal deaths due to HIV not declining despite PMTCT successes in South Africa
